165 related articles for article (PubMed ID: 38334832)
1. Automated analysis of choroidal thickness in patients with systemic lupus erithematosus treated with hydroxychloroquine.
Arias-Peso B; Chacón González M; García-Navarro D; Ruiz Del Tiempo MP; Pardiñas Barón N; Sáez-Comet L; Ruiz-Moreno O; Bartol-Puyal F; Méndez-Martínez S; Pablo Júlvez L
Int Ophthalmol; 2024 Feb; 44(1):40. PubMed ID: 38334832
[TBL] [Abstract][Full Text] [Related]
2. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
Ahn SJ; Ryu SJ; Joung JY; Lee BR
Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
[TBL] [Abstract][Full Text] [Related]
3. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
Forte R; Haulani H; Dyrda A; Jürgens I
Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
[TBL] [Abstract][Full Text] [Related]
4. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
Ahn SJ; Ryu SJ; Lim HW; Lee BR
Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of retinal and choroidal vascularity in systemic lupus erythematosus by SS-OCT/OCTA.
Guo T; Jin Y; Zhou M; Lei B; Huang L; Chen S; Xue K
Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3385-3393. PubMed ID: 37367994
[TBL] [Abstract][Full Text] [Related]
6. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
[TBL] [Abstract][Full Text] [Related]
7. Retinal and Choroidal Changes in Patients with Parkinson's Disease Detected by Swept-Source Optical Coherence Tomography.
Satue M; Obis J; Alarcia R; Orduna E; Rodrigo MJ; Vilades E; Gracia H; Otin S; Fuertes MI; Polo V; Larrosa JM; Pablo LE; Garcia-Martin E
Curr Eye Res; 2018 Jan; 43(1):109-115. PubMed ID: 29111842
[TBL] [Abstract][Full Text] [Related]
8. Choroid thickness profile in patients with lupus nephritis.
Braga J; Rothwell R; Oliveira M; Rodrigues D; Fonseca S; Varandas R; Ribeiro L
Lupus; 2019 Apr; 28(4):475-482. PubMed ID: 30755143
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
Bulut M; Akıdan M; Gözkaya O; Erol MK; Cengiz A; Çay HF
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of subclinical retinopathy and angiopathy with OCT and OCTA in patients with systemic lupus erythematosus.
Işık MU; Akmaz B; Akay F; Güven YZ; Solmaz D; Gercik Ö; Kabadayı G; Kurut İ; Akar S
Int Ophthalmol; 2021 Jan; 41(1):143-150. PubMed ID: 32851556
[TBL] [Abstract][Full Text] [Related]
11. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
Martín-Iglesias D; Artaraz J; Fonollosa A; Ugarte A; Arteagabeitia A; Ruiz-Irastorza G
Lupus; 2019 Apr; 28(4):555-559. PubMed ID: 30755141
[TBL] [Abstract][Full Text] [Related]
12. Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
Wakiya R; Ueeda K; Shimada H; Nakashima S; Kameda T; Miyatake N; Kato M; Miyagi T; Sugihara K; Mizusaki M; Mino R; Kadowaki N; Dobashi H
Clin Rheumatol; 2022 Nov; 41(11):3345-3353. PubMed ID: 35849246
[TBL] [Abstract][Full Text] [Related]
13. Visual Impact of Early Hydroxychloroquine-Related Retinal Structural Changes in Patients with Systemic Lupus Erythematosus.
Sallam MA; Beltagi AS; Abdellatif MA; Awadalla MA
Ophthalmologica; 2021; 244(4):301-308. PubMed ID: 34015786
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjögren Syndrome: A Potential Association with Therapies.
Conigliaro P; Triggianese P; Draghessi G; Canofari C; Aloe G; Chimenti MS; Valeri C; Nucci C; Perricone R; Cesareo M
Int Arch Allergy Immunol; 2018; 177(1):45-56. PubMed ID: 29902805
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine in systemic lupus erythematosus (SLE).
Ponticelli C; Moroni G
Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
[TBL] [Abstract][Full Text] [Related]
16. Altered microvascular density in patients with systemic lupus erythematosus treated with hydroxychloroquine-an optical coherence tomography angiography study.
Mihailovic N; Leclaire MD; Eter N; Brücher VC
Graefes Arch Clin Exp Ophthalmol; 2020 Oct; 258(10):2263-2269. PubMed ID: 32533282
[TBL] [Abstract][Full Text] [Related]
17. The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine.
Sakai R; Honda S; Tanaka E; Majima M; Konda N; Takada H; Harigai M
Lupus; 2020 Nov; 29(13):1712-1718. PubMed ID: 32838624
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
19. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
